APA (7th ed.) Citation

Leweke, F. M., Fritze, S., & Köthe, D. (2018). Role of the endocannabinoid system in the pathophysiology of Schizophrenia: Implications for pharmacological intervention. CNS drugs, 32(7), . https://doi.org/10.1007/s40263-018-0539-z

Chicago Style (17th ed.) Citation

Leweke, F. Markus, Stefan Fritze, and Dagmar Köthe. "Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological Intervention." CNS Drugs 32, no. 7 (2018). https://doi.org/10.1007/s40263-018-0539-z.

MLA (9th ed.) Citation

Leweke, F. Markus, et al. "Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological Intervention." CNS Drugs, vol. 32, no. 7, 2018, https://doi.org/10.1007/s40263-018-0539-z.